Bruce Caswell - Maximus Pres and General Manager of Global Health Services
| MMS Stock | USD 80.82 0.16 0.20% |
Executive
Mr. Bruce L. Caswell is re designated as President, Chief Executive Officer of the Company effective April 1, 2018. He previously served as the President of our Health Services Segment from 2007 through 2014. Before that he was President of Operations from 2005 to 2007 and President of our Human Services Group from 2004 to 2005. Previously, he worked at IBM Corporation for nine years, serving most recently as Vice President, State and Local Government Education Industries for IBM Business Consulting Services. Mr. Caswell holds a Masters Degree in Public Policy from the John F. Kennedy School of Government at Harvard University and a B.A. in Economics from Haverford College. The board of directors believes that Mr. Caswell should serve as a director based on his qualifications and skills which include, among other things, his subject matter expertise in government policy and health and human services programs together with his detailed knowledge of the Company operations gained through his service as our President and other senior leadership positions at the Company. Mr. Caswell is being nominated for election to the board of directors in connection with his transition to Chief Executive Officer effective April 1, 2018. The board of directors believes that it is important to have the Companys chief executive also serve as a director. since 2018.
| Age | 57 |
| Tenure | 6 years |
| Address | 1600 Tysons Boulevard, McLean, VA, United States, 22102 |
| Phone | 703 251 8500 |
| Web | https://www.maximus.com |
Latest Insider Transactions
Maximus Management Efficiency
The company has Return on Asset of 0.0497 % which means that on every $100 spent on assets, it made $0.0497 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1127 %, implying that it generated $0.1127 on every 100 dollars invested. Maximus' management efficiency ratios could be used to measure how well Maximus manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Maximus' Return On Tangible Assets are comparatively stable compared to the past year. Return On Equity is likely to gain to 0.21 in 2024, whereas Return On Capital Employed is likely to drop 0.1 in 2024. At this time, Maximus' Intangibles To Total Assets are comparatively stable compared to the past year. Debt To Assets is likely to gain to 0.34 in 2024, whereas Deferred Long Term Asset Charges is likely to drop slightly above 1.2 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Robert CPA | Network 1 Technologies | 57 | |
| Kari Marquis | First Advantage Corp | N/A | |
| Tara Mackey | AZZ Incorporated | 54 | |
| Brian Bruce | BrightView Holdings | N/A | |
| Kinloch Gill | BrightView Holdings | 47 | |
| Rachel Canham | Rentokil Initial PLC | 42 | |
| Ryan Robinson | BrightView Holdings | 55 | |
| Tiffany Moseley | AZZ Incorporated | 52 | |
| Bob Batz | CBIZ Inc | N/A | |
| Daniel Schleiniger | BrightView Holdings | N/A | |
| Steven Janssen | CBIZ Inc | N/A | |
| Stephanie Gorman | First Advantage Corp | N/A | |
| Rolf Bezemer | First Advantage Corp | N/A | |
| Kin Gill | BrightView Holdings | 49 | |
| Michael Gleespen | CBIZ Inc | 65 | |
| Joelle Smith | First Advantage Corp | 48 | |
| Chris Stoczko | BrightView Holdings | N/A | |
| Erica Mannion | AZZ Incorporated | N/A | |
| Ray Nobile | BrightView Holdings | N/A | |
| Matthew Morelli | CBIZ Inc | N/A | |
| Sara Spivey | BrightView Holdings | 54 | |
Management Performance
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0497 |
Maximus Leadership Team
Elected by the shareholders, the Maximus' board of directors comprises two types of representatives: Maximus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Maximus. The board's role is to monitor Maximus' management team and ensure that shareholders' interests are well served. Maximus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Maximus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Akbar Piloti, General Manager of Global Human Services | ||
| Bruce Caswell, Pres and General Manager of Global Health Services | ||
| Elisabeth Schmidt, Senior Services | ||
| Derrick Pledger, Chief Officer | ||
| David Francis, General Counsel, Secretary | ||
| Peter Pond, Non-Executive Independent Chairman of the Board | ||
| John Lambeth, Chief Officer | ||
| Jessica Batt, VP ESG | ||
| Theresa Golinvaux, Senior Officer | ||
| Julia Bailey, Senior Compliance | ||
| Ilene Baylinson, General Manager, U.S. Services | ||
| Teresa Weipert, General Manager, U.S. Federal Services | ||
| Richard Montoni, Co-Vice Chairman and Senior Advisor to the Chief Executive Officer | ||
| John Martinez, General Officer | ||
| John Boyer, Chairman Foundation | ||
| Thomas Romeo, General Manager, U.S. Federal Services | ||
| James Thompson, Independent Director | ||
| Wellington Webb, Independent Director | ||
| Lisa Miles, Vice President - Investor Relations & Corporate Communications | ||
| Michael Warren, Independent Director | ||
| Russell Beliveau, Independent Director | ||
| Marilyn Seymann, Independent Director | ||
| Paul Lederer, Independent Director | ||
| Gayathri Rajan, Independent Director | ||
| Jan Madsen, Independent Director | ||
| David Mutryn, Chief Financial Officer, Treasurer | ||
| Mark Andrekovich, Chief of Human Capital and President of Tax and Employer Services | ||
| Raymond Ruddy, Independent Vice Chairman of the Board | ||
| Anne Altman, Independent Co-Vice Chairman of the Board | ||
| Michelle Link, Chief Human Resource Officer | ||
| Eileen Rivera, Vice Relations | ||
| Jericho Seguin, Senior Planning | ||
| Richard Nadeau, Chief Financial Officer, Treasurer | ||
| John Haley, Independent Non-Executive Chairman of the Board |
Maximus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Maximus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0497 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 6.32 B | |||
| Shares Outstanding | 61.03 M | |||
| Shares Owned By Insiders | 1.01 % | |||
| Shares Owned By Institutions | 99.10 % | |||
| Number Of Shares Shorted | 631.71 K | |||
| Price To Earning | 19.50 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maximus. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For more information on how to buy Maximus Stock please use our How to Invest in Maximus guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Maximus Stock analysis
When running Maximus' price analysis, check to measure Maximus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maximus is operating at the current time. Most of Maximus' value examination focuses on studying past and present price action to predict the probability of Maximus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maximus' price. Additionally, you may evaluate how the addition of Maximus to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Maximus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maximus. If investors know Maximus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maximus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.6 | Dividend Share 1.16 | Earnings Share 3.02 | Revenue Per Share 81.445 | Quarterly Revenue Growth 0.062 |
The market value of Maximus is measured differently than its book value, which is the value of Maximus that is recorded on the company's balance sheet. Investors also form their own opinion of Maximus' value that differs from its market value or its book value, called intrinsic value, which is Maximus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maximus' market value can be influenced by many factors that don't directly affect Maximus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maximus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maximus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maximus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.